Patient Protection And Affordable Care Act: Fraud Risks in the Advance Premium Tax Credit
Description
This testimony before the House Committee on the Judiciary, Subcommittees on the Administrative State, Regulatory Reform, and Antitrust and Oversight, discusses the preliminary results of our work on fraud risk management in the advance premium tax credit.
It is based primarily on the following report:
Patient Protection and Affordable Care Act: Preliminary Results from Ongoing Review Suggest Fraud Risks in the Advance Premium Tax Credit Persist
So far, we've found that fraud risks have persisted since we first reported on this from 2014 to 2016. For example, we were able to obtain subsidized insurance for fake enrollees. The program hasn't updated its fraud risk assessment since 2018 and its fraud risks have evolved.
It is based primarily on the following report:
Patient Protection and Affordable Care Act: Preliminary Results from Ongoing Review Suggest Fraud Risks in the Advance Premium Tax Credit Persist
So far, we've found that fraud risks have persisted since we first reported on this from 2014 to 2016. For example, we were able to obtain subsidized insurance for fake enrollees. The program hasn't updated its fraud risk assessment since 2018 and its fraud risks have evolved.